Third

UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims

UCLA investigators reviewed pharmaceutical ads in American medical journals and found that nearly one-third contained no references for medical claims; while the majority of references to published material was available, only a minority of company data-on-file documents were provided upon request; and the majority of original research cited in the ads was funded by or had authors affiliated with...

Study finds more than one-third of human genome regulated by RNA

For many years, DNA and proteins have beenviewed as the real movers and shakers in genomic studies, with RNA seenas little more than a messenger that shuttles information between thetwo. But researchers from Whitehead Institute for Biomedical Researchand Massachusetts Institute of Technology have discovered that smallRNA molecules called microRNAs regulate thousands of human genes--morethan...

Sustainable farm practices improve Third World food production

Crop yields on farms in developing countries that used sustainable agriculture rose nearly 80 percent in four years, according to a study scheduled for publication in the Feb. 15 issue of the American Chemical Society journal . The study, the largest of its kind to date -- 286 farm projects in 57 countries -- concludes that sustainable agriculture p...

Lizard 'third eye' sheds light on evolution of color vision

Published in the March 17 issue of Science, their lizard study describes how the "side-blotched" lizard's so-called third, or parietal, eye, distinguishes two different colors, blue and green, possibly to tell the time of day. Specialized nerve cells in that eye, which looks more like a spot on the lizard's forehead, use two types of molecular signals to sense light: those found only in simpler...

One-third of adults with diabetes still don't know they have it

The prevalence of diagnosed diabetes in U.S. adults age 20 and older has risen from about 5.1 percent to 6.5 percent, according to researchers at the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), who analyzed national survey data from two periods--1988 to 1994 and 1999 to 2002. However, the percentage of adults with undiagnosed diabetes did not cha...

More>>

Third at Biology Products

No data found

Search Third biology products at Google

Search Third biology products at Yahoo

Search Third biology products at Msn

Third at Biology Technology

Stratagene to pay Third Wave $10.75M in patent case

The case, which was litigated in U.S. District Court for the We...

Third Wave receives FDA clearance of pharmacogenetic test

It is the first pharmacogenetic test to be approved by the FDA for use as a companion diagnostic to a specific drug therapy. The test is c...

Third Wave continues molecular diagnostic focus with new CEO

MADISON , is transitioning to the position of executive chairman in order to focus on the assessment and development of next-generation technologies. In addition, the company announced that <a href="ht...

Third Wave lands European distribution deal, reports high earnings

MADISON announced Tuesday a four-year marketing and distribution agreement. Under the terms of the agreement, Third Wave has granted Belgium-based Innogenetics the exclusive European marketing and distribution rights for select Invader molecu...

Third Wave releases reagents for Hepatitis C testing

MADISON - The Hepatitis C virus is the leading cause of liver disease in the United States and affects 4 million Americans, leading to about 10,000 deaths annually, according to a co...

More>>

Third at Medicine News

Third artificial heart patient introduced

The third man to receive an experimental artificial heart made his first public appearance, three-and-a-half months after getting the device.// Bobby Harrison appeared at a news conference with members of his surgical team from the Texas Heart Institute, where he underwent surgery on September 26, 2001. The AbioCor heart is a battery-powered plastic-and-titanium device that's complet...

Extra hormone found to cut appetite by a third

Studies done previously have shown that the hormone could suppress the appetites of lean people. But researchers were worried it would not work in obese people because studies of another appetite-suppressing hormone,// leptin, had proved disappointing. "We had to do a second trial to see if obese people were as sensitive" to the hormone, said researchers. The answer: "Yes, they are. The...

Third generation Small pox vaccine from Cell-culture

Richard Greenberg and colleagues compared their Cell culture small pox vaccine// (CCSV) derived from cell culture with calf lymph derived vaccine. Small pox vaccine currently used is a live, attenuated vaccine virus derived from calf lymph. This vaccine produces adverse effects in vaccinated, 15-42 develop serious or life threatening adverse reactions of every million. 1 to 2 people every million...

Surgery Offers Better Treatment For Third Degree Piles

Hemorrhoids or Piles has become one of the most common diseases.// Almost half of the population will encounter hemorrhoids by the age of 50. Incidence of hemorrhoids is more in men compared to women at occurs mostly between the ages of 45 to 65. Surgical removal and Rubber band ligation (RBL) are the mostly used procedure for treatment of hemorrhoids. Surgical removal of severe hemorrh...

One Third Of All Cancers Preventable!

Prevention is better than cure remains a golden statement that has withstood the test of time. It has been proved yet another time with a global survey revealing that nearly one-third of all cancers // can be prevented if nine major culprits are properly taken care of. The study was part of an overall Initiative for Global Health. Amongst, the modifiable risk factors, tobacco leads the m...

More>>

Third at Medicine Products

PSA, Third Generation

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Third-Generation TSH

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Third at Medicine Technology

Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis

- Multinational Phase III Study Meets Primary Endpoint inRheumatoid Arthritis Patients Who Failed to Respond to Anti-tumorNecrosis Factor Treatments - NUTLEY, N.J., July 10, 2007 /PRNewswire/ -- Roche todayannounced that results from the Actemra Radiate (RheumAtoiDArthritIs Study in Anti-TNF FailurEs) trial successfully met itsprimary endpoint in patients with moderate to severe rheumatoi...

Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference

FORT LEE, N.J.--(BUSINESS WIRE)--Jul 6, 2007 - Neurologix, Inc.(OTCBB:NRGX), a biotechnology company engaged in the development ofinnovative gene therapies for the brain and central nervous system,announced today that the company will present at the Third AnnualC.E. Unterberg Towbin Emerging Growth Conference on Tuesday July10, 2007 at 4:30 pm ET at The Mandarin Oriental Hotel in New York.<...

Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke

CHICAGO--(BUSINESS WIRE)--Jun 25, 2007 - Pfizer announced todaythat Lipitor (atorvastatin calcium) Tablets 80 mg reduced the riskof stroke, coronary heart disease events and major coronary eventsin type 2 diabetes patients who had no known coronary heart diseasebut who had experienced a recent stroke or mini-stroke, comparedwith placebo. The results are from a new analysis of the landmarkSt...

Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology

PETACH TIKVA, Israel--(BUSINESS WIRE)--Jun 14, 2007 - Can-FiteBioPharma (TASE:CFBI), a biotechnology company traded on the TelAviv Stock Exchange Exchange, proceeds with the development of itsthird drug CF502; this is in addition to CF101, which is currentlyin clinical trials and CF102, which is in preclinical phases. Thisweekend Can-Fite will present at the EUALR annual congress ofrheumato...

One-Third of Patients Discontinue Common Breast Cancer Therapy

PRINCETON, N.J.--(BUSINESS WIRE)--Mar 15, 2007 - An alarming studythat appeared in the March 1, 2007 issue of CANCER (a peer-reviewedjournal of the American Cancer Society), reports that one-third ofwomen taking the standard five-year regimen of the hormonal breastcancer treatment tamoxifen citrate, discontinue therapy early.(1) According to the authors, non-compliance with tamoxifen table...

More>>